EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark BRIUMVI was filed as Word mark on 06/10/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/29/2021.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018489086 |
| Application date | June 10, 2021 |
| Publication date | June 22, 2021 |
| Entry date | September 29, 2021 |
| Expiration date | June 10, 2031 |
Trademark owner
2 Gansevoort Street, 9th Floor
10014 New York
US
10014 New York
US
Trademark representatives
Ferdinand-Happ-Str. 32
60314 Frankfurt
DE
goods and services
5
Pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of central nervous system disorders, multiple sclerosis, autoimmune diseases and B-cell mediated non-oncological diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 17, 2024 | RAW: Licences - Licences granted, Published | ||
| January 11, 2023 | Change Representative, Published | ||
| November 15, 2021 | RAW: Trade mark - Partial Surrender, Published |
ID: 11018489086